Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Non-Current Liabilities (2023 - 2026)

Camp4 Therapeutics' Total Non-Current Liabilities history spans 3 years, with the latest figure at $25.3 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 67.14% to $25.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.3 million, a 67.14% increase, with the full-year FY2025 number at $25.3 million, up 67.14% from a year prior.
  • Total Non-Current Liabilities hit $25.3 million in Q4 2025 for Camp4 Therapeutics, up from $11.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for CAMP hit a ceiling of $25.3 million in Q4 2025 and a floor of $11.0 million in Q3 2025.
  • Historically, Total Non-Current Liabilities has averaged $15.5 million across 3 years, with a median of $15.2 million in 2024.
  • The widest YoY moves for Total Non-Current Liabilities: up 67.14% in 2025, down 39.55% in 2025.
  • Tracing CAMP's Total Non-Current Liabilities over 3 years: stood at $16.5 million in 2023, then decreased by 8.25% to $15.2 million in 2024, then soared by 67.14% to $25.3 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CAMP at $25.3 million in Q4 2025, $11.0 million in Q3 2025, and $11.3 million in Q2 2025.